BioSyent Inc. (CVE:RX – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$11.06 and traded as high as C$11.13. BioSyent shares last traded at C$10.80, with a volume of 869 shares.
BioSyent Price Performance
The firm has a market capitalization of C$123.52 million, a P/E ratio of 17.53 and a beta of 0.93. The business’s fifty day moving average is C$11.06 and its 200 day moving average is C$11.14. The company has a current ratio of 3.92, a quick ratio of 6.91 and a debt-to-equity ratio of 2.90.
About BioSyent
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
See Also
- Five stocks we like better than BioSyent
- Options Trading – Understanding Strike Price
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- What Does a Stock Split Mean?
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
